CASI Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CASI and other ETFs, options, and stocks.About CASI
CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing innovative therapeutics and pharmaceutical products. The firm is also involved in developing innovative therapeutics addressing cancer and other unmet medical needs for the global market.
CEODavid A. Cory
CEODavid A. Cory
Employees233
Employees233
HeadquartersBeijing, Beijing
HeadquartersBeijing, Beijing
Founded1991
Founded1991
Employees233
Employees233
CASI Key Statistics
Market cap13.17M
Market cap13.17M
Price-Earnings ratio-0.27
Price-Earnings ratio-0.27
Dividend yield—
Dividend yield—
Average volume31.03K
Average volume31.03K
High today$0.8615
High today$0.8615
Low today$0.8615
Low today$0.8615
Open price—
Open price—
Volume100.00
Volume100.00
52 Week high$3.29
52 Week high$3.29
52 Week low$0.75
52 Week low$0.75
Stock Snapshot
As of today, CASI Pharmaceuticals(CASI) shares are valued at $0.85. The company's market cap stands at 13.17M, with a P/E ratio of -0.27.
CASI Pharmaceuticals(CASI) stock opened on 2026-01-07 at —. The price climbed to $0.86 and dipped to $0.86.
The CASI Pharmaceuticals(CASI)'s current trading volume is 100, compared to an average daily volume of 31.03K.
In the last year, CASI Pharmaceuticals(CASI) shares hit a 52-week high of $3.29 and a 52-week low of $0.75.
In the last year, CASI Pharmaceuticals(CASI) shares hit a 52-week high of $3.29 and a 52-week low of $0.75.
People also own
Based on the portfolios of people who own CASI. This list is generated using Robinhood data, and it’s not a recommendation.